{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:35:45Z","timestamp":1774330545037,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1023\/b:ddas.0000042246.58984.98","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T21:05:15Z","timestamp":1095800715000},"page":"1458-1460","source":"Crossref","is-referenced-by-count":38,"title":["CASE REPORT: Pneumocystis carinii Pneumonia with Oral Candidiasis After Infliximab Therapy for Crohn's Disease"],"prefix":"10.1007","volume":"49","author":[{"given":"Nirmal","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Mahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"495607_CR1","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S, et al.:Infliximab for the treatment of fistulas in patients with Crohn's disease. N Eng J Med 340:1398\u20131405, 1999","journal-title":"N Eng J Med"},{"key":"495607_CR2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1345\/aph.1C249","volume":"37","author":"RN Serio","year":"2003","unstructured":"Serio RN: Infliximab treatment of sarcoidosis. Ann Pharmacother 37:577\u2013581, 2003","journal-title":"Ann Pharmacother"},{"key":"495607_CR3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","volume":"344","author":"A Warris","year":"2001","unstructured":"Warris A: Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 344:1099\u20131100, 2001","journal-title":"N Engl J Med"},{"key":"495607_CR4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(01)00945-7","volume":"112","author":"M Nakelchik","year":"2002","unstructured":"Nakelchik M, Mangino JE: Reactivation of histoplasmosis after treatment with infliximab. Am J Med 112:78, 2002","journal-title":"Am J Med"},{"key":"495607_CR5","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00042737-200212000-00018","volume":"14","author":"D Helbling","year":"2002","unstructured":"Helbling D, Breichtback TH, Kraus M: Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol 14:1393\u20131395, 2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"495607_CR6","first-page":"410","volume":"34","author":"BM Kamath","year":"2002","unstructured":"Kamath BM, Mamula P, Baldassano RN, Markowitz JE: Listeria meningitis after treatment with infliximab. J Pediatr Gastroenterol Nutr 34:410\u2013412, 2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"495607_CR7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1572-0241.2000.01872.x","volume":"95","author":"J Morelli","year":"2000","unstructured":"Morelli J, Wilson FA: Does infliximab therapy increase susceptibility to listeriosis? Am J Gastroenterol 95:841\u2013842, 2000","journal-title":"Am J Gastroenterol"},{"key":"495607_CR8","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, et al.: Tuberculosis associated with infliximab, a tumor-necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098\u20131104, 2001","journal-title":"N Engl J Med"},{"key":"495607_CR9","first-page":"100","volume":"61","author":"DW Hommes","year":"2003","unstructured":"Hommes DW, Van Deventer SJH: Infliximab therapy in Crohn's disease: safety issues. Neth J Med 61:100\u2013104, 2003","journal-title":"Neth J Med"},{"key":"495607_CR10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1572-0241.2003.07368.x","volume":"98","author":"SR Puli","year":"2003","unstructured":"Puli SR, Benage DD: Retinal vein thrombosis after infliximab (remicade) treatment for Crohn's disease. Am J Gastroenterol 98:939, 2003","journal-title":"Am J Gastroenterol"},{"key":"495607_CR11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-138-10-200305200-00008","volume":"138","author":"HJ Kwon","year":"2003","unstructured":"Kwon HJ, Cote TR, Cuffe MS, et al.: Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 138:807\u2013811, 2003","journal-title":"Ann Intern Med"},{"key":"495607_CR12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/rheumatology\/41.8.951","volume":"41","author":"TL Tai","year":"2002","unstructured":"Tai TL, O'Rourke P, McWeeney M, et al.: Pneumocystis carinii pneumonia following a second infusion of infliximab. Rheumatology 41:951\u2013952, 2002","journal-title":"Rheumatology"},{"key":"495607_CR13","unstructured":"FDA: Safety update on TNF-a antagonists: infliximab and etanercept. Food and Drug Administration, Center for Biologics Evaluation and Research, Arthritis Advisory Committee Meeting, August 17, 2001 (http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/01\/briefing\/3779b2.htm)"},{"key":"495607_CR14","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/art.11301","volume":"48","author":"T Ellerin","year":"2003","unstructured":"Ellerin T, Rubin RH, Weinblatt ME: Infections and anti-tumor necrosis factor ? therapy. Arth Rheum 48:3013\u20133022, 2003","journal-title":"Arth Rheum"},{"key":"495607_CR15","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.4049\/jimmunol.159.12.6276","volume":"159","author":"AE Plevy","year":"1997","unstructured":"Plevy AE, Landers CJ, Prehn J, et al.: A role for TNF-a and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 159:6276\u20136282, 1997","journal-title":"J Immunol"},{"key":"495607_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2249.1990.tb03334.x","volume":"81","author":"TT MacDonald","year":"1990","unstructured":"MacDonald TT, Hutchings P, Choy MY, et al.: Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 81:301, 1990","journal-title":"Clin Exp Immunol"},{"key":"495607_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(99)70224-6","volume":"116","author":"FJ Baert","year":"1999","unstructured":"Baert FJ, D'Haens GR, Peeters M, et al.: Tumor necrosis factor(alpha) antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116:22\u201328, 1999","journal-title":"Gastroenterology"},{"key":"495607_CR18","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","volume":"124","author":"JMH Van Den Brande","year":"2003","unstructured":"Van Den Brande JMH, Braat H, Van Den Brink GR, et al.: Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patient's with Crohn's disease. Gastroenterology 124:1774\u20131785, 2003","journal-title":"Gastroenterology"},{"key":"495607_CR19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1398-9995.1997.tb00968.x","volume":"52","author":"AG Oehling","year":"1997","unstructured":"Oehling AG, Akdis CA, Schapowal A, et al.: Suppression of the immune system by oral glucocorticoid therapy in brochial asthma. Allergy 52:144\u2013154, 1997","journal-title":"Allergy"},{"key":"495607_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00384-002-0431-6","volume":"18","author":"A Shand","year":"2003","unstructured":"Shand A, Forbes A: Potential therapeutic role for cytokine or adhesion molecule manipulation in Crohn's disease: in the shadow of infliximab? Int J Colorectal Dis 18:1\u201311, 2003","journal-title":"Int J Colorectal Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000042246.58984.98.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:DDAS.0000042246.58984.98\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DDAS.0000042246.58984.98.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T03:38:27Z","timestamp":1753760307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:DDAS.0000042246.58984.98"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["495607"],"URL":"https:\/\/doi.org\/10.1023\/b:ddas.0000042246.58984.98","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}